Axert and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Axert (almotriptan malate), especially for people who are female, 50-59 old, also take Actemra, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Rashes when taking Axert. It is created by eHealthMe based on reports of 1,106 people who have side effects when taking Axert from the FDA, and is updated regularly.

What is Axert?

Axert has active ingredients of almotriptan malate. It is often used in migraine. eHealthMe is studying from 1,175 Axert users. Check the latest studies of Axert.

What is Rashes?

Rashes (redness) is found to be associated with 3,712 drugs and 6,213 conditions by eHealthMe. Check the latest studies of Rashes.

On Jul, 13, 2026

1,106 people reported to have side effects when taking Axert.
Among them, 57 people (5.15%) have Rashes.

Among these 57 people:

What is the gender of people who have Rashes when taking Axert? *

female: 98.18 %
male: 1.82 %

What is the age of people who have Rashes when taking Axert? *

What are other drugs people take besides Axert? *

What are other side effects people have besides Rashes? *

Headache (pain in head): 27 people, 47.37%
Nausea (feeling of having an urge to vomit): 27 people, 47.37%
Fatigue (feeling of tiredness): 27 people, 47.37%
Dizziness: 26 people, 45.61%
High Blood Pressure: 20 people, 35.09%
Pain: 20 people, 35.09%
Dyspnea (difficult or laboured breathing): 19 people, 33.33%
Urticaria (rash of round, red welts on the skin that itch intensely): 18 people, 31.58%
Weakness: 18 people, 31.58%
Nausea And Vomiting: 17 people, 29.82%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 20 people, 35.09%
Asthma: 8 people, 14.04%
Dizziness: 7 people, 12.28%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 6 people, 10.53%
Irritable Bowel Syndrome: 6 people, 10.53%
Hypersensitivity: 5 people, 8.77%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 4 people, 7.02%
Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 3 people, 5.26%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 5.26%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 3 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Axert and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Axert:

Axert (1,175 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Axert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,712 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,213 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on almotriptan malate (the active ingredients of Axert) and Axert (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.